Overview
What is Global Solutions For Infectious Diseases?
Global Solutions for Infectious Diseases (GSID) is a nonprofit organization based in Lafayette, California, dedicated to expanding the development of affordable diagnostic and preventive tools for infectious diseases primarily impacting less developed countries. Their primary mission involves conducting research and developing vaccines and diagnostics for life-threatening infectious diseases, such as HIV. GSID collaborates with global public health organizations, private foundations, and for-profit entities to facilitate access to cost-effective health solutions, benefiting those in need in developing countries. In 2022, their sole program service area was serving as the manufacturing and product sponsor for the AIDSVAX vaccine, maintaining a manufacturing reagents repository, and clinical trial databases. They completed product stability testing for their vaccine to qualify it for human clinical trials, which has been undergoing an ongoing Phase 2B trial in three sub-Saharan African countries since 2020. Funding for their activities comes from the Henry M. Jackson Foundation and Imperial College, London, the sponsor of the aforementioned clinical trial.
Official website here: www.gsid.org
Is Global Solutions For Infectious Diseases legitimate?
Global Solutions For Infectious Diseases is a legitimate nonprofit organization registered as a 501(c)(3) entity. Global Solutions For Infectious Diseases submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $636,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Global Solutions For Infectious Diseases?
Global Solutions for Infectious Diseases (GSID) is dedicated to expanding the creation of affordable and effective diagnostic and preventative tools for infectious diseases affecting less developed nations. Their primary charitable mission involves conducting research on and developing vaccines and diagnostics for life-threatening infectious diseases, such as HIV. Additionally, GSID collaborates with various global public health organizations, private foundations, and for-profit entities to facilitate access to affordable health solutions, benefiting the most in need individuals in developing countries.
Official website here: www.gsid.org
Who is the CEO of Global Solutions For Infectious Diseases?
Carter A Lee is the Executive Director of Global Solutions For Infectious Diseases.
Official website here: www.gsid.org
What is the revenue of Global Solutions For Infectious Diseases?
Global Solutions For Infectious Diseases's revenue in 2022 was $961,683.
Official website here: www.gsid.org
Who are the executives of Global Solutions For Infectious Diseases and what are their salaries?
The average compensation at Global Solutions For Infectious Diseases during 2022 was $106,000. There are 6 employees and 1 volunteers at Global Solutions For Infectious Diseases.
Here are 3 key members and their salaries:
- Carter A Lee (Executive Director)
- Faruk M Sinangil (Board Member) [Trustee/Director]
- Dr Seung-Il Shin (Board Member) [Trustee/Director]
Official website here: www.gsid.org
Where can I find the form 990 for Global Solutions For Infectious Diseases?
The Global Solutions For Infectious Diseases’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.gsid.org
Learn more at the official website: www.gsid.org
Mission Statement of Global Solutions For Infectious Diseases
Global Solutions for Infectious Diseases (GSID) is dedicated to expanding the development of affordable and effective diagnostic and preventive tools for infectious diseases that pose a significant threat in less developed countries. The organization's primary mission is to conduct research and develop vaccines and diagnostics for life-threatening infectious diseases, such as HIV. GSID is committed to collaborating with various global public health organizations, private foundations, and for-profit entities focused on public health issues. This collaboration aims to facilitate access to affordable health solutions, benefiting those in developing countries who are most in need. By doing so, GSID seeks to contribute to the global fight against infectious diseases, particularly in less developed regions.
Impact
This information is meant to be a general summary of Global Solutions For Infectious Diseases. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 1, 2024
Global Solutions For Infectious Diseases has a significant impact on global public health through its focus on developing low-cost effective tools for the diagnosis and prevention of infectious diseases in less developed countries. The organization's AIDSVAX HIV vaccine program has been a key initiative, with a primary goal of expanding access to life-saving vaccines and diagnostics for diseases like HIV.
By serving as the manufacturing and product sponsor for the AIDSVAX vaccine, Global Solutions For Infectious Diseases has played a crucial role in advancing research and development in the field of infectious diseases. The completion of product stability testing in 2022 marked an important milestone in qualifying the vaccine for human clinical trials, particularly in sub-Saharan African countries where the need for effective HIV prevention is high.
Through partnerships with institutions like the Henry M. Jackson Foundation and Imperial College, London, Global Solutions For Infectious Diseases has been able to secure funding and support for its activities, demonstrating a collaborative approach to addressing global health challenges. By conducting research, developing vaccines, and providing assistance to other public health organizations, the organization is making a tangible difference in the lives of people in developing countries who are most in need of affordable health solutions.
Overall, Global Solutions For Infectious Diseases' commitment to medical research and its dedication to improving global public health make a valuable impact in the fight against infectious diseases, creating opportunities for greater access to essential healthcare solutions worldwide.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2004
Phone
(650) 228-7908
Principal Officer
Carter A Lee
Main Address
3527 MT DIABLO BLVD 478, LAFAYETTE, CA, 94549
Website
www.gsid.org
NTEE Category
Code: H81 - Medical research
If you are a representative of Global Solutions For Infectious Diseases and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.